[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mo et al., 2005 - Google Patents

Targeting Ubc9 for cancer therapy

Mo et al., 2005

Document ID
17148320674025542222
Author
Mo Y
Moschos S
Publication year
Publication venue
Expert opinion on therapeutic targets

External Links

Snippet

Ubiquitin-conjugating enzyme (Ubc9) was originally thought to be a conjugating enzyme for ubiquitylation, but was later shown to be responsible for the most recently identified type of post-translational modification,(ie, SUMO [small ubiquitin-related modifier]) conjugation or …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Mo et al. Targeting Ubc9 for cancer therapy
Chan et al. The Hippo pathway in biological control and cancer development
Pandey et al. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer
Visser et al. LATS tumor suppressor: a new governor of cellular homeostasis
Irvine et al. Rasputin, more promiscuous than ever: a review of G3BP
Kim et al. Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability
Hall et al. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage
Xu et al. Regulation of protein stability by GSK3 mediated phosphorylation
Li et al. USP26 promotes esophageal squamous cell carcinoma metastasis through stabilizing Snail
US8211635B2 (en) P53 modulator and cancer target
Yokoi et al. Two mammalian homologs of yeast Rad23, HR23A and HR23B, as multifunctional proteins
AU8010800A (en) Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
CN108707668A (en) A kind of long non-coding RNA SNHG15 and its application in preparing diagnosis and treatment cancer drug
Feng et al. SUMO modification of menin
Wu et al. Ubiquitin-like protein modifications in prostate and breast cancer
Date et al. Borealin is repressed in response to p53/Rb signaling
US8759301B2 (en) Gene fusion targeted therapy
Seghatoleslam et al. Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours
Buddaseth et al. Dysregulation of cell cycle control caused by overexpression of the oncogene pp32r1 (ANP32C) and the Tyr> His mutant pp32r1Y140H
EP2855532A1 (en) Identification and functional expression of the mitochondrial pyruvate carrier, mpc1
Joutsen Regulation of cellular stress proteins in physiology and disease
Gérus et al. Crosstalk between ribosome synthesis and cell cycle progression and its potential implications in human diseases
CN111363034B (en) Antibody of NANOG Ser68, inhibitor and application
Qiao et al. Unraveling the Oncogenic Characteristics of the Cytolinker, Plectin, in Esophageal Squamous Cell Carcinoma
Escuder-Rodríguez et al. Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai